Company intelligence / Profile preview

Schwabe Group

Ownership: Private
Employees: ~4000
Development stage: Commercial

Overview

The Schwabe Group develops and markets clinically proven phytopharmaceuticals and homeopathic medicines worldwide, with leading brands such as Tebonin® (Ginkgo biloba) supported by extensive clinical research. Its portfolio includes prescription drugs, OTC remedies, and supplements based on plant-derived active ingredients. The group operates globally with over €950 million annual sales (~2023), employing about ~4,000 people.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Phytopharmaceuticals (standardized herbal extracts and medicines)Homeopathic medicines
Industry: Biotech

Drug pipeline

26 assets

Vitano

25 more assets in the full pipeline.

Request access →

Partnerships

Numerous licensing/distribution partners globally; specifics not detailed in public sources.

Beyond the preview

Go deeper on Schwabe Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schwabe Group.

Explore the full profile